Top list · Worldwide
40 biomarkers startups worldwide have raised money in rounds we track. These are the 40 that have raised the most, $420M between them, with the United States the most common home.
Exai Bio is a biotechnology company based in Palo Alto, California, founded in 2021.
Founded 2021Palo Alto, United States$68Mlast round Dec 2021Brainomix Limited is a medical technology and digital health company based in Oxford, England.
Founded 2010Oxford, United Kingdom$52Mlast round Mar 2025Quibim is a healthtech and biotechnology company based in Valencia, Spain, specializing in AI-powered quantitative imaging biomarkers.
Founded 2015Valencia, Spain$50Mlast round Jan 2025Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Founded 2018New York, United States$45Mlast round Apr 2026Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.
Founded 2019Berkeley, United States$42Mlast round Apr 2025Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.
Founded 2020Westport, United States$40Mlast round Feb 2026Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Founded 2017Norwich, United Kingdom$14Mlast round Mar 2025MDoloris Medical Systems is a French MedTech company founded in 2010, specializing in innovative technologies for monitoring the Autonomic Nervous System (ANS).
Founded 2010Loos, France$11Mlast round Jul 2018Abcodia is a biotechnology company that focuses on the discovery and validation of biomarkers for cancer screening.
Founded 2010Cambridge, United Kingdom$10Mlast round May 2015RetiSpec is a Toronto-based medical AI and imaging company founded in 2016.
Founded 2016Toronto, Canada$10Mlast round Jul 2024neotiv is a German digital health company founded in 2017, focused on developing digital cognitive biomarkers for the early detection of Alzheimer’s disease and
Founded 2017Magdeburg, Germany$10Mlast round Nov 2022Rare Biomarkers, Delivered Reliably preserving and delivering rare biomarkers and assays to the clinic.
Founded 2004San Diego, United States$9.2Mlast round Dec 2012IncellDx is a single-cell diagnostic company focused on advancing Precision Medicine.
Founded 2009San Carlos, United States$9.0Mlast round May 2012SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.
Founded 2002Hohen Neuendorf, Germany$5.5Mlast round Aug 2024CIS Biotech is a research and development company bringing disease-associated biomarkers and in vitro diagnostic tools to the marketplace.
Founded 2000United States$4.0Mlast round Oct 2013Elo develops a smart nutrition service that uses biomarkers to deliver nutrition for optimal health and aging.
Founded 2020San Francisco, United States$3.5Mlast round Mar 2025Gina Life is femtech company developing a platform of biomarkers strategy supported by AI for early detection in women’s health space.
Founded 2020Haifa$3.1Mlast round Aug 2023Affinergy is a biotechnology company based in Research Triangle Park, North Carolina, founded in 2003.
Founded 2003Morrisville, United States$3.0Mlast round Mar 2006At Noah Labs, we empower patients with cardiovascular conditions to live healthier, longer lives by developing voice-based biomarkers for early detection and en
Founded -Berlin, United States$2.8Mlast round Sept 2026AgenT is a life sciences company on a mission to defeat Alzheimer's disease by targeting the silent phase.
Founded 2018Paris, France$2.7Mlast round Jul 2021Critical Diagnostics is a biotechnology company based in San Diego, California, founded in 2004.
Founded 2004San Diego, United States$2.6Mlast round Mar 2013Inbiomotion is a biotechnology company based in Barcelona that specializes in precision medicine.
Founded 2010Barcelona, Spain$2.5Mlast round Jun 2012PREVIA MEDICAL is a French deeptech startup based in Lyon, specializing in predictive healthcare technology and artificial intelligence.
Founded 2020Lyon, France$2.4Mlast round Aug 2023Kascaid is a U.S.
Founded 2018United States$2.3Mlast round Jun 2025Brainify.AI is a New York-based AI company founded in 2021 that focuses on precision psychiatry platforms.
Founded 2021New York, United States$2.3Mlast round Aug 2025NanoDetection Technology develops an integrated computer chip containing discrete diodes for the rapid detection of multiple biomarkers.
Founded 2002United States$2.3Mlast round Jul 2011MSInsight is a French health-tech company founded in 2022, specializing in precision oncology.
Founded 2022Paris, France$1.7Mlast round Mar 2025Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics.
Founded 2022Amsterdam, Netherlands$1.6Mlast round Jan 2025SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.
Founded 2011Washington DC, United States$1.6Mlast round Apr 2014nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.
Founded 2016Cambridge, United States$1.5Mlast round Nov 2021Imageens is a healthtech company based in Paris, founded in 2017.
Founded 2017Paris, France$1.4Mlast round Apr 2021DMI Life Sciences develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation.
Founded 2009United States$1.2Mlast round Apr 2009Genie Fertility is a London-based biotechnology startup established in 2024, specializing in reproductive health and non-invasive fertility diagnostics.
Founded -London, United Kingdom$1.2Mlast round Sept 2025Neurolytixs has utilized machine learning to look for unique biomarkers derived from the brain.
Founded 2020Toronto, Canada$1.0Mlast round Nov 2020Senseye, Inc.
Founded 2015Austin, United States$450Klast round Jun 2015Anacalypsis Therapeutics is a biotechnology company that develops medications and biomarkers for neurodegenerative diseases.
Founded -Pikérmi, Greece$344Klast round Sept 2026AtG Therapeutics is a biotechnology company based in L’Hospitalet de Llobregat, Barcelona, Spain, founded in 2021.
Founded 2022L'Hospitalet de Llobregat, Spain$214Klast round Jun 2024Generating digital biomarkers for women's heart health with patented textile sensor technology
Founded 2017Cambridge, United States$200Klast round May 2025PLC Diagnostics offers a diagnostic testing platform for the detection of molecular biomarkers.
Founded 2006Los Angeles, United States$184Klast round Apr 2011Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.
Founded 2010Oxford, United Kingdom$167Klast round Jun 2024Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back biomarkers startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B